Page 162 - Read Online

Pergolini et al. J Cancer Metastasis Treat 2018;4:33 I http://dx.doi.org/10.20517/2394-4722.2017.84 Page 11 of 11

Roviello F, Coniglio A, de Manzoni G. Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0
resection? Ann Surg Oncol 2015;22:589-96.
39. Tsujimoto H, Ichikura T, Ono S, Sugasawa H, Hiraki S, Sakamoto N, Yaguchi Y, Hatsuse K, Yamamoto J, Hase K. Outcomes for
patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 2010;4:406-13.
40. Viganò L, Vellone M, Ferrero A, Giuliante F, Nuzzo G, Capussotti L. Liver resection for gastric cancer metastases. Hepatogastroenterology
2013;60:557-62.
41. Wang YN, Shen KT, Ling JQ, Gao XD, Hou YY, Wang XF, Qin J, Sun YH, Qin XY. Prognostic analysis of combined curative resection
of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg 2012;12:20.
42. Wang W, Liang H, Zhang H, Wang X, Xue Q, Zhang R. Prognostic significance of radical surgical treatment for gastric cancer patients
with synchronous liver metastases. Med Oncol 2014;31:1-8.
43. Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzl E, Mühlbacher F, Jakesz R, Längle F. Analysis of hepatic resection of metastasis
originating from gastric adenocarcinoma. J Gastrointest Surg 2002;6:682-9.
44. Shiono S, Sato T, Horio H, Chida M, Matsuguma H, Ozeki Y, Nakajima J, Okumura S. Outcomes and prognostic factors of survival
after pulmonary resection for metastatic gastric cancer. Eur J Cardiothorac Surg 2013;43:e13-6.
45. Yoshida Y, Imakiire T, Yoneda S, Obuchi T, Inada K, Iwasaki A. Ten cases of resected solitary pulmonary metastases arising from
gastric cancer. Asian Cardiovasc Thorac Ann 2013;22:578-82.
46. Iijima Y, Akiyama H, Atari M, Fukuhara M, Nakajima Y, Kinosita H, Uramoto H. Pulmonary resection for metastatic gastric cancer.
Ann Thorac Cardiovasc Surg 2016;22:230-6.
47. Kobayashi Y, Fukui T, Ito S, Shitara K, Ito S, Hatooka S, Mitsudomi T. Pulmonary metastasectomy for gastric cancer: a 13-year single-
institution experience. Surg Today 2013;43:1382-9.
48. Li C, Yan M, Chen J, Xiang M, Zhu ZG, Yin HR, Lin YZ. Survival benefit of non-curative gastrectomy for gastric cancer patients with
synchronous distant metastasis. J Gastrointest Surg 2010;14:282-8.
49. Ko KJ, Shim JH, Yoo HM, Il SO, Jeon HM, Park CH, Jeon DJ, Song KY. The clinical value of non-curative resection followed by
chemotherapy for incurable gastric cancer. World J Surg 2012;36:1800-5.
50. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJH. Value of palliative resection in gastric cancer. Br J
Surg 2002;89:1438-43.
51. Saidi RF, ReMine SG, Dudrick PS, Hanna NN. Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World
J Surg 2006;30:21-7.
52. Kokkola A, Louhimo J, Puolakkainen P. Does non-curative gastrectomy improve survival in patients with metastatic gastric cancer? J
Surg Oncol 2012;106:193-6.
53. Samarasam I, Chandran BS, Sitaram V, Perakath B, Nair A, Mathew G. Palliative gastrectomy in advanced gastric cancer: is it
worthwhile? ANZ J Surg 2006;76:60-3.
54. Lin SZ, Tong HF, You T, Yu YJ, Wu WJ, Chen C, Zhang W, Ye B, Li CM, Zhen ZQ, Xu JR, Zhou JL. Palliative gastrectomy and
chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol 2008;134:187-92.
55. Sougioultzis S, Syrios J, Xynos ID, Bovaretos N, Kosmas C, Sarantonis J, Dokou A, Tzivras D, Zografos G, Felekouras E, Papalambros
E, Tsavaris N. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving
chemotherapy: a retrospective analysis. Eur J Surg Oncol 2011;37:312-8.
56. Funakoshi T, Yasui H, Boku N, Fukutomi A, Yamazaki K, Machida N, Todaka A, Tsushima T, Yokota T, Onozawa Y, Kenmotsu H, Endo
M. Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa. Jpn J Clin Oncol
2014;44:792-8.
57. Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg
1965;49:357-63.
58. Fujitani K, Yang HK, Mizusawa J, Kim YW, Terashima M, Han SU, Iwasaki Y, Hyung WJ, Takagane A, Park DJ, Yoshikawa T, Hahn
S, Nakamura K, Park CH, Kurokawa Y, Bang YJ, Park BJ, Sasako M, Tsujinaka T16; REGATTA study investigators. Gastrectomy
plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3,
randomised controlled trial. Lancet Oncol 2016;17:309-18.
59. Waddell T, Chau I, Cunningham D, Gonzalez D, Frances A, Okines C, Wotherspoon A, Saff C, Middleton G, Wadsley J, Ferry D,
Mansoor W, Crosby T, Coxon F, Smith D, Waters J, Iveson T, Falk S, Slater S, Peckitt C, Barbachano Y. Epirubicin, oxaliplatin, and
capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a
randomised, open-label phase 3 trial. Lancet Oncol 2013;14:481-9.
60. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E,
Hill J, Lehle M, Rüschoff J, Kang YK; ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy
alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label,
randomised controlled trial. Lancet 2010;376:687-97.
61. Liao YY, Peng NF, Long D, Yu PC, Zhang S, Zhong JH, Li LQ. Hepatectomy for liver metastases from gastric cancer: a systematic
review. BMC Surg 2017;17:14.
62. Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, Zhou B, Xu H. Clinical significance of palliative gastrectomy on the survival of patients
with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2013;13:577.
63. Krasniqi E, Pellicori S, Formica V. Emerging role of S-1 in gastric cancer. Indian J Med Paediatr Oncol 2015;36:219-28.